Valganciclovir (Valganciclovir)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceValganciclovirValganciclovir
Similar drugsTo uncover
  • Valganciclovir
    pills inwards 
    Aurobindo Pharma Co., Ltd.     India
  • Valganciclovir
    pills inwards 
    IRVIN 2, LLC     Russia
  • Valganciclovir-Teva
    pills inwards 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
  • Valcit®
    pills inwards 
    Hoffmann-La Roche Ltd.     Switzerland
  • Tsivilgan
    pills inwards 
    IZVARINO PHARMA, LLC     Russia
    • Dosage form: & nbspfilm-coated tablets
    ATX: & nbsp

    J.05.A.B.14   Valganciclovir

    J.05.A.B   Nucleosides and nucleotides

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004780
    Date of registration:03.04.2018
    Expiration Date:03.04.2023
    The owner of the registration certificate:IRVIN 2, LLC IRVIN 2, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp25.04.2018
    Illustrated instructions
      Instructions
      Up
      talkdrugs

      +8 (800)555-35-35

      [email protected]

      The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

      The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

      It is forbidden to copy any instructions of medicines,biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

      All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.